[ TRANSACTION RECORD ]

Pfizer Inc. Investment in Genomic Health Research — 2026

VERIFIED VECTOR ID: 002725 · tx-440
M SOURCE NODE — FUNDER
Pfizer Inc.
Healthcare United States
$1,200,000,000
EQUITY
15/01/2026
Q DESTINATION NODE — RECIPIENT
Genomic Health Research
SPV Switzerland
Amount (USD)
$1.2B
Flow Type
EQUITY
Transaction Date
15/01/2026
Primary Source
View Filing ↗
Funder Profile [ M ]
Entity Pfizer Inc.
AUM 190000
HQ Location United States
Sector Healthcare
Recipient Profile [ Q ]
Entity Genomic Health Research
Entity Type SPV
Jurisdiction Switzerland
Intelligence Note

Pfizer Inc. completed a 1.2 billion dollar equity investment in the Genomic Health Research facility in Switzerland to advance personalized medicine through large-scale data analysis. This transaction provides the capital for clinical innovation and the development of next-generation therapies for genetic diseases. The deal highlights the high institutional value of genomic health technology.

Σ
Primary Forensic Source https://www.pfizer.com/news/press-release/2026/pfizer-genomic-health-research-investment/
✓ SOURCE LINKED